Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 8.

Schnegg-Kaufmann, A; Feller, A; Baldomero, H; Rovo, A; Manz, M G; Gregor, M; Efthymiou, A; Bargetzi, M; Hess, U; Spertini, O; Chalandon, Y; Passweg, J R; Stussi, G; Arndt, V; Bonadies, N; NICER Working Group; Rohrmann, Sabine (2018). Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013. Cancer Epidemiology, 52:55-62.

Gössi, F; Spahn, M; Zweifel, M; Panagiotis, S; Mischo, A; Stenner, F; Hess, U; Berthold, D; Bargetzi, M; Schardt, J; Pabst, T (2017). Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse. Bone Marrow Transplantation, 52(2):334-336.

Terwijn, M; van Putten, W L; Kelder, A; van der Velden, V H; Brooimans, R A; Pabst, T; Maertens, J; Boeckx, N; de Greef, G E; Valk, P J; Preijers, F W; Huijgens, P C; Dräger, A M; Schanz, U; Jongen-Lavrecic, M; Biemond, B J; Passweg, J R; van Gelder, M; Wijermans, P; Graux, C; Bargetzi, M; Legdeur, M C; Kuball, J; de Weerdt, O; Chalandon, Y; Hess, U; Verdonck, L F; Gratama, J W; Oussoren, Y J; Scholten, W J; Slomp, J; Snel, A N; Vekemans, M C; Löwenberg, B; Ossenkoppele, G J; Schuurhuis, G J (2013). High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: Data from the HOVON/SAKK AML 42A Study. Journal of Clinical Oncology, 31(31):3889-3897.

Passweg, J R; Baldomero, H; Bargetzi, M; Bucher, C; Chalandon, Y; Duchosal, M A; Gratwohl, A; Güngör, T; Hess, U; Leibundgut, K; de Faveri, G N; Ozsahin, H; Pabst, T; Renner, C; Stern, M; Stussi, G; Schanz, U (2013). Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss Medical Weekly, 143:w13757.

Renner, C; Zinzani, P L; Gressin, R; Klingbiel, D; Dietrich, P Y; Hitz, P; Bargetzi, M; Mingrone, W; Martinelli, G; Trojan, A; Bouabdallah, K; Lohri, A; Gyan, E; Biaggi, C; Cogliatti, S; Bertoni, F; Ghielmini, M; Brauchli, P; Ketterer, N (2012). A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma. Haematologica, 97(7):1085-1091.

Vellenga, E; van Putten, W; Ossenkoppele, G J; Verdonck, L F; Theobald, L F; Cornelisson, J J; Huijgens, P C; Maertens, J; Gratwohl, A; Schaafsma, R; Schanz, U; Graux, C; Schouten, H C; Ferrant, A; Bargetzi, M; Fey, M F; Löwenberg, B (2011). Autologous peripheral blood stem cell transplantation for acute myeloid leukemia. Blood, 118(23):6037-6042.

Krayenbuehl, P A; Hersberger, M; Truninger, K; Müllhaupt, B; Maly, F E; Bargetzi, M; Schulthess, G (2010). Toll-like receptor 4 gene polymorphism modulates phenotypic expression in patients with hereditary hemochromatosis. European Journal of Gastroenterology & Hepatology, 22(7):835-841.

Passweg, J; Baldomero, H; Stern, M; Bargetzi, M; Ghielmini, M; Leibundgut, K; Duchosal, M; Hess, U; Seger, R; Buhrfeind, E; Schanz, U; Gratwohl, A (2010). Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effect. Swiss Medical Weekly, 140(23-24):326-334.

This list was generated on Sun Feb 24 07:00:26 2019 CET.